Arrowhead Pharmaceuticals
ARWR
#1966
Rank
A$14.53 B
Marketcap
A$103.78
Share price
1.81%
Change (1 day)
376.46%
Change (1 year)

Earnings for Arrowhead Pharmaceuticals (ARWR)

Earnings in 2025 (TTM): A$0.55 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current earnings are A$1.09 Billion. , an increase over its 2024 earnings that were of -A$0.84 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arrowhead Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 A$0.47 B-157.5%
2024 -A$0.84 Billion112.45%
2023 -A$0.4 Billion87.79%
2022 -A$0.21 Billion-20.1%
2021 -A$0.27 Billion67.59%
2020 -A$0.16 Billion-347.53%
2019 A$62.97 M-245.59%
2018 -A$43.26 Million-13.17%
2017 -A$49.82 Million-52.28%
2016 -A$0.11 Billion-16.57%
2015 -A$0.13 Billion30.32%
2014 -A$96.02 Million171.62%
2013 -A$35.35 Million16.56%
2012 -A$30.33 Million107.53%
2011 -A$14.62 Million
2008 -A$51.48 Million-8.07%
2007 -A$56 Million70.37%
2006 -A$32.87 Million122.51%
2005 -A$14.78 Million147.41%
2004 -A$5.97 Million2002.28%
2003 -A$0.29 Million-85.61%
2002 -A$1.98 Million1371.97%
2001 -A$0.14 Million-13.45%
2000 -A$0.16 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$46.54 B 9,621.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-A$3.83 Billion-899.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$0.22 B-52.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-A$0.17 Billion-134.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$0.79 B 66.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-A$0.15 Billion-131.32%๐Ÿ‡บ๐Ÿ‡ธ USA